Cargando…
Efficacy and Durability of Intratympanic Gentamicin Treatment for Meniere's Disease
Objective: To study the success of intratympanic gentamicin (ITG) treatment in reducing vertigo attacks in Meniere's disease (MD) and the value of the Halmagyi head thrust test (HTT) in predicting treatment durability. Study Design: Retrospective cohort study. Setting: Tertiary care vestibular...
Autores principales: | Guan, Yafeng, Chari, Divya A., Liu, Yu-Hsi, Rauch, Steven D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695721/ https://www.ncbi.nlm.nih.gov/pubmed/34956051 http://dx.doi.org/10.3389/fneur.2021.765208 |
Ejemplares similares
-
Intratympanic gentamicin for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023) -
Editorial: Intratympanic and surgical treatment for Meniere's disease
por: Yang, Jun, et al.
Publicado: (2022) -
Intratympanic Gentamicin for Intractable Ménière's Disease – A Review and Analysis of Audiovestibular Impact
por: Yetişer, Sertaç
Publicado: (2018) -
Low-Dose Intratympanic Gentamicin for Unilateral Ménière‘s Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome
por: Wegmann-Vicuña, Ricardo, et al.
Publicado: (2022) -
Intratympanic corticosteroids for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)